Genmab A/S S/Adr

(GMXAY)

By |

Profile

Genmab is a cancer drug developer, best known for its antibody technology platforms, DuoBody and HexaBody, and its promising first-in-class multiple myeloma drug Darzalex (daratumumab), which is partnered with J&J. The company also has several pipeline candidates targeting other oncologic indications and autoimmune diseases.

Contact Information

Website: www.genmab.com
Email: r.gravesen@genmab.com
Main Phone: +45 70202728
Address: Kalvebod Brygge 43
Address 2: 1560
City / Town: Copenhagen V
Country: DNK
Postal Code: 1260

Issuer Information

Exchange: OTO
Employees: 309
$ 15.19 $ -0.275 (-1.78%)
Last Price 15.19 Change $ -0.275 Change % -1.78 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 15.46 High 15.47 Low 15.11 Prev Close 15.46
Last Trade Volume 82,668 52 Wk Hi 21.68 52 Wk Low 12.10
Market Cap 9.3 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 613,715,690.00 EPS (TTM) 0.33 PE Ratio 51.40 Exchange OTCPK